investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Preclinical Evaluation of Crucell's Ad26 and Ad35, in Intravaginal Vaccination in Mouse Models
John Schiller
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Preclinical Evaluation of Crucell's Ad26 and Ad35, in Intravaginal Vaccination in Mouse Models
Related projects
Shawn B Bratton
Degradation mechanisms for inhibitor of apoptosis proteins and their antagonists
All cancers but non-melanoma skin cancer
Dennis Klinman
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
All cancers but non-melanoma skin cancer
Randal S Tibbetts
Genome maintenance functions of CREB/ATF transcription factors
All cancers but non-melanoma skin cancer
Charles Roberts
The function of Snf5, an epigenetic tumor suppressor
All cancers but non-melanoma skin cancer
Steven A Carr
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
All cancers but non-melanoma skin cancer
Investigator from VU University Amsterdam
ONCOgenic Receptor Network of Excellence and Training
All cancers but non-melanoma skin cancer
Georges Mer
Post-translational Modifications in DNA Damage Response: a Structural Perspective
All cancers but non-melanoma skin cancer
Hans-Martin Herz
Trithorax-related, MLL3 and MLL4 in enhancer-mediated cancer pathogenesis
All cancers but non-melanoma skin cancer
Alan Perantoni
Growth/Differentiation Factors in Organogenesis
All cancers but non-melanoma skin cancer
